Cotización Aptorum - APM

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

0.736

Postura de Compra

0.6501

Postura de Venta

0.80

Volume Operado de la Acción

0.00 Rango del Día 0.00

0.46 Rango de 52 semanas 17.49

Capitalización de Mercado [m]

3.814M

Precio Anterior

0.736

Precio de Apertura

Hora

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

33,185

Acciones en circulación

5,181,697

Rendimiento del Dividendo

Ratio Precio/Utilidad

-1.36

Beneficio por acción (BPA)

-0.55

turnover

431k

Beneficio neto

-2.83M

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company opera... Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. Its lead projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.aptorumgroup.com

Sede

Grand Cayman, Cym

Fundado

Aptorum Group Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APM. The last closing price for Aptorum was US$0.74. Over the last year, Aptorum shares have traded in a share price range of US$ 0.46 to US$ 17.49.

Aptorum currently has 5,181,697 shares in issue. The market capitalisation of Aptorum is US$3.81 million. Aptorum has a price to earnings ratio (PE ratio) of -1.36.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group” or “We”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business

Aptorum Group Limited (Nasdaq: APM), a clinical stage biopharmaceutical company (“Aptorum”), and privately-held YOOV Group Holding Ltd. (“YOOV”) jointly announced today that they entered into an...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.444	-37.6271186441	1.18	1.23	0.46	154652	0.66752431	CS
4	-0.974	-56.9590643275	1.71	1.76	0.46	60746	0.92451999	CS
12	-2.344	-76.1038961039	3.08	3.09	0.46	33185	1.36957623	CS
26	-4.024	-84.5378151261	4.76	5.63	0.46	22435	2.19181169	CS
52	-0.854	-53.7106918239	1.59	17.49	0.46	617841	8.29835795	CS
156	-20.664	-96.5607476636	21.4	23.5	0.46	492750	12.48314377	CS
260	-157.461	-99.5347572963	158.197	182.5	0.46	485049	21.17156116	CS

Símbolo	Precio	Vol.
WORXSCWorx Corporation	US$ 1.85 (88.78%)	14.78M
AKTSAkoustis Technologies Inc	US$ 0.12985 (49.08%)	52.03M
PETWag Group Company	US$ 0.312 (48.50%)	16.27M
CRKNCrown Electrokinetics Corporation	US$ 1.13 (43.83%)	4.35M
ESGROEnstar Group Ltd	US$ 28.00 (40.92%)	24
WSBFWaterstone Financial Inc	US$ 9.00 (-40.98%)	4
TRSTriMas Corporation	US$ 15.62 (-40.79%)	3
BCAXBicara Therapeutics Inc	US$ 11.00 (-40.15%)	208
XNCRXencor Inc	US$ 15.11 (-36.30%)	2
PYXSPyxis Oncology Inc	US$ 2.44 (-36.13%)	201.93k
AKTSAkoustis Technologies Inc	US$ 0.12985 (49.08%)	52.03M
PETWag Group Company	US$ 0.312 (48.50%)	16.27M
WORXSCWorx Corporation	US$ 1.85 (88.78%)	14.78M
XTKGX3 Holdings Company Ltd	US$ 0.0797 (-11.44%)	10.59M
CRKNCrown Electrokinetics Corporation	US$ 1.13 (43.83%)	4.35M

Símbolo

Precio

Vol.